ADC drug

This innovative drug company has so far brought only two products to market, and its high sales expenses make investors worry about fallout from an anti-corruption drive.

RemeGen hopes for pain relief from expanded drug uses

The innovative drug company has so far brought only two products to market, and its high sales expenses make investors worry about fallout from an anti-corruption drive Key Takeaways: RemeGen’s…
9995.HK 688331.SHG

Recent Articles

RELATED ARTICLES

  1. WuXi Biologics is spinning off its WuXi XDC ADS unit
    WuXi Biologics hatches new baby with ADC drug unit IPO
    2269.HK
  2. AstraZeneca pays hefty price for Chinese weight-loss drug
    AZN.US
  3. HBM gets health boost from drug licensing deals
    2142.HK
  4. Everest reaches new heights on growing drug sales
    1952.HK
  5. BeiGene still bleeding red ink despite blockbuster drug
    BGNE.US 6160.HK 688235.SHG
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo File-alt

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva